• Home >
  • Publications >
  • Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

1 Oct 2020Gynecologic Oncology

DOI : 10.1016/j.ygyno.2020.07.025

Authors

Ana Oaknin, Claire F. Friedman, Lynda D. Roman, Anishka D'Souza, Irene Brana, François-Clement Bidard, Jonathan Goldman, Edwin A. Alvarez, Valentina Boni, Adam C. ElNaggar, Rodolfo Passalacqua, Khanh T.M. Do, Alessandro D. Santin, Kiana Keyvanjah, Feng Xu, Lisa D. Eli, Alshad S. Lalani, Richard P. Bryce, David M. Hyman, Funda Meric-Bernstam, David B. Solit, Bradley J. Monk